Polomar Health Services Inc. Stock Analysis PMHS
Polomar Health Services, Inc. engages in health care services. The company is headquartered in Palm Harbor, Florida and currently employs 2 full-time employees. The company went IPO on 2008-11-10. Polomar Specialty Pharmacy is also licensed as a Special Sterile Compounding Pharmacy, which authorizes the licensed entity to dispense injectable and other sterile compounds (eye drops, infused therapeutics) upon receipt of a valid prescription. The firm also owns SlimRx (www.slimrx.com), a weight-loss focused online platform that connects patients with licensed physicians to prescribe weight-loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin (VitaSlim and VitaSlim Plus). The firm also focuses on launching PoloMeds (polomeds.com) to fulfill prescriptions for diabetes medications, including metformin compounds, sulfonylureas, and insulin; compounded erectile dysfunction medications inhalable sildenafil and Polomar’s prescription only, exclusive dermatological formulations.
Read More Polomar Health Services Inc (PMHS) Chart
Key Statistics of Polomar Health Services Inc (PMHS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.30Volume
300.00P/E Ratio (TTM)
-52 Week Range
Market Cap
3.37MAvg. Volume
234.67Dividend Yield
-Financial Metrics & Statements of Polomar Health Services Inc (PMHS)
FAQ's for Polomar Health Services Inc (PMHS)
- According to Musaffa’s Shariah screening methodology, Polomar Health Services Inc (PMHS) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.